Drug
Fluticasone Propionate And Salmeterol Inhalation
Fluticasone Propionate And Salmeterol Inhalation: highest development phase Phase 3, developed by Teva. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| Fluticasone Propionate and Salmeterol Inhalation Powder NCT03756883 | Phase 3 | Asthma |
Latest
No recent events.
Follow Fluticasone Propionate And Salmeterol Inhalation on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.